AAAAAA

   
Results: 1-7 |
Results: 7
Image-aided estimate of tumor burden in Hodgkin's disease: Evidence of itsprimary prognostic importance
Authors: Gobbi, PG Ghirardelli, ML Solcia, M Di Giulio, G Merli, F Tavecchia, L Berte, R Davini, O Levis, A Broglia, C Maffe, GC Ilariucci, F Dore, R Ascari, E
Citation: Pg. Gobbi et al., Image-aided estimate of tumor burden in Hodgkin's disease: Evidence of itsprimary prognostic importance, J CL ONCOL, 19(5), 2001, pp. 1388-1394
Designing clinical trials on gastric lymphomas and reporting outcomes
Authors: Gobbi, PG Broglia, C Broglia, F Ascari, E
Citation: Pg. Gobbi et al., Designing clinical trials on gastric lymphomas and reporting outcomes, HAEMATOLOG, 86(8), 2001, pp. 785-790
Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems
Authors: Gobbi, PG Zinzani, PL Broglia, C Comelli, M Magagnoli, M Federico, M Merli, F Iannitto, E Tura, S Ascari, E
Citation: Pg. Gobbi et al., Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems, CANCER, 91(8), 2001, pp. 1467-1478
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease
Authors: Gobbi, PG Broglia, C Berte, R Petrilli, MP Molica, S Angrilli, F Iannitto, E Ghirardelli, ML Di Renzo, N Cavanna, L Ascari, E
Citation: Pg. Gobbi et al., Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease, HAEMATOLOG, 85(7), 2000, pp. 722-728
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas
Authors: Gobbi, PG Ghirardelli, ML Cavalli, C Baldini, L Broglia, C Clo, V Berte, R Ilariucci, F Carotenuto, M Piccinini, L Stelitano, C Attardo-Parrinello, G Ascari, E
Citation: Pg. Gobbi et al., The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas, HAEMATOLOG, 85(4), 2000, pp. 372-380
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL)
Authors: Gobbi, PG Ghirardelli, ML Avanzini, P Baldini, L Quarta, G Stelitano, C Broglia, C Loni, C Silingardi, V Ascari, E
Citation: Pg. Gobbi et al., A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL), HAEMATOLOG, 85(3), 2000, pp. 263-268
Stoichiometric deviations and partial-pressure measurements in solid-vapour cadmium telluride system
Authors: Zappettini, A Bissoli, F Zanotti, L Zha, M Broglia, C Paorici, C
Citation: A. Zappettini et al., Stoichiometric deviations and partial-pressure measurements in solid-vapour cadmium telluride system, MATER CH PH, 66(2-3), 2000, pp. 138-142
Risultati: 1-7 |